Published: January 27th 2026 | Updated: January 31st 2026
Milestone Approvals, Evolving PBM Models May Redefine the 2026 Biosimilar Landscape
Published: February 3rd 2021 | Updated: January 31st 2026
Poll: How Much Do You Know About Biosimilars in China?
Published: December 8th 2025 | Updated: January 31st 2026
Biosimilar QL1207 Demonstrates Equivalent Efficacy and Safety in DME
Published: November 27th 2025 | Updated: January 31st 2026
Biosimilar Interchangeability and Substitution in the US: What Comes Next?
Published: November 30th 2025 | Updated: January 31st 2026
All Things Biosimilars: How Streamlined CES Rules Could Shift the Market
Published: September 9th 2025 | Updated: January 31st 2026
Switch to Biosimilar Adalimumab Found Safe and Cost-Saving for Patients With IBD